Loading dose of quinine in African children with cerebral malaria
- PMID: 9861410
- DOI: 10.1016/s0035-9203(98)91032-x
Loading dose of quinine in African children with cerebral malaria
Abstract
The majority of deaths from cerebral malaria occur within 48 h after admission to hospital. Because of the possibility of inadequate treatment within this period, the use of a loading dose of quinine has been proposed. We reviewed clinical and laboratory data for 113 children with cerebral malaria, who were treated with intravenous quinine, 10 mg/kg every 8 h, at Macha Mission Hospital in rural Zambia. In 1990-1991, 39 children were not given a loading dose of quinine while, in 1992-1993, 74 children received a loading dose of 20 mg/kg. Elevated serum iron levels, as reflected in transferrin saturation, were strongly associated with higher mortality. A loading dose of quinine was associated with faster recovery from coma and enhanced clearance of parasitaemia and fever. The loading dose was also associated with trends to lower mortality and higher haemoglobin levels, but these differences were not statistically significant.
Similar articles
-
Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria.Trans R Soc Trop Med Hyg. 1998 Mar-Apr;92(2):214-8. doi: 10.1016/s0035-9203(98)90753-2. Trans R Soc Trop Med Hyg. 1998. PMID: 9764337 Clinical Trial.
-
Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria.N Engl J Med. 1992 Nov 19;327(21):1473-7. doi: 10.1056/NEJM199211193272101. N Engl J Med. 1992. PMID: 1406879 Clinical Trial.
-
[Treatment of cerebral malaria in African children by intravenous quinine: comparison of a loading dose regimen to a regimen without a loading dose].Arch Pediatr. 2002 Jun;9(6):587-94. doi: 10.1016/s0929-693x(01)00925-3. Arch Pediatr. 2002. PMID: 12108312 Clinical Trial. French.
-
Clinical studies of iron chelators in malaria.Acta Haematol. 1996;95(1):78-86. doi: 10.1159/000203953. Acta Haematol. 1996. PMID: 8604591 Review.
-
Neurological manifestations of falciparum malaria.Ann Neurol. 1998 Jun;43(6):695-702. doi: 10.1002/ana.410430603. Ann Neurol. 1998. PMID: 9629838 Review.
Cited by
-
Cerebral malaria: optimising management.CNS Drugs. 2003;17(3):153-65. doi: 10.2165/00023210-200317030-00002. CNS Drugs. 2003. PMID: 12617695 Review.
-
High first dose quinine regimen for treating severe malaria.Cochrane Database Syst Rev. 2004;2004(3):CD003341. doi: 10.1002/14651858.CD003341.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266481 Free PMC article.
-
Cerebral malaria.J Neurol Neurosurg Psychiatry. 2000 Oct;69(4):433-41. doi: 10.1136/jnnp.69.4.433. J Neurol Neurosurg Psychiatry. 2000. PMID: 10990500 Free PMC article. Review.
-
Artesunate versus quinine for treating severe malaria.Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD005967. doi: 10.1002/14651858.CD005967.pub4. Cochrane Database Syst Rev. 2012. PMID: 22696354 Free PMC article.
-
Population pharmacokinetics of intramuscular quinine in children with severe malaria.Antimicrob Agents Chemother. 2001 Jun;45(6):1803-9. doi: 10.1128/AAC.45.6.1803-1809.2001. Antimicrob Agents Chemother. 2001. PMID: 11353629 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical